FONDAZIONE TLS has served as the Host Institution for six ERC research projects in the fields of vaccinology and infectious diseases, and has collaborated with leading national and international organizations and agencies, such as the Wellcome Trust, AIRC, Wellcome Leap, and the Horizon Europe program.

SCIENTIFIC PUBLICATIONS: In 2025, 22 articles authored by TLS researchers were published in prestigious international scientific journals—such as Nature, Proceedings of the National Academy of Sciences (PNAS), Frontiers in Immunology, Nucleic Acids Research, and Science Translational Medicine —bringing the total number of TLS articles published since 2019 to 166.

TLS: In 2025, the workforce consists of 61 employees and 8 PhD students:
– 57% are women (88% of the PhD students are women)
– 84% of those working at TLS hold at least a university degree
– 51% have completed specialized training through courses, master’s programs, or PhDs

THE BIOINCUBATOR (Financial data as 31.12.2025)
– 43 entities (16 incubated companies, 12 research bodies/foundations, and 15 affiliated companies/organizations)
– €28.5 million in revenue
– Over €214 million in funding attracted since 2007, including €19 million in 2025
– 3 new patents granted (76 in total since 2007)
– 77 patent applications filed (since 2007)
– 12 new products launched on the market (373 in total since 2007)
– 80 articles published in prestigious industry journals, bringing the total to 1.103 papers since 2007
– 385 people employed